Enfusion Forecast, price target & analysts
$10.76
0.00%
Nasdaq,
Mon, Apr 21 2025
Sector
Industry
Enfusion Target price 2025 - Analyst rating & recommendation
Powered by
Enfusion Classifications & Recommendation:
Hold
50%
Sell
50%
Enfusion Price Target
| Target Price | $11.25 |
| Price | $10.76 |
| Potential |
4.55%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Enfusion price target 2026.
The average Enfusion target price is $11.25.
This is
4.55%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend Enfusion to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Enfusion stock has an average upside potential 2026 of
4.55%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 201.61 | 232.32 |
| 15.51% | 15.23% | |
| EBITDA Margin | 8.88% | 20.55% |
| 29.33% | 167.12% |
1 Analyst has issued a sales forecast Enfusion 2025 . The average Enfusion sales estimate is
$232m
Unlock
15.23%
higher
Unlock
$232m
15.23%
Unlock
$232m
15.23%
Unlock
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Enfusion 2025 . The average Enfusion EBITDA estimate is
$47.7m
Unlock
207.83%
higher
Unlock
$47.7m
207.83%
Unlock
$47.7m
207.83%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | 4.36 |
Current Enfusion Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| William Blair |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| Stifel |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
William Blair:
Locked
➜
Locked
|
Jan 13 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
Stifel:
Locked
➜
Locked
|
Dec 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
